1.40 USD
↗ 0.07 (5.26%)AT CLOSE (11:59 AM EDT)
Dare Bioscience, Inc. Common Stock
DARENASDAQ • USD
1.39
↘ 0.01 (0.43%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
1.39
↘ 0.01 (0.43%)
Market: CLOSED
Dare Bioscience, Inc. Common Stock (DARE) is currently trading at $1.40. Technicals currently rate "Sell" while our fundamental analysis reads "Neutral". Notable factors include a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place DARE at a fair price relative to peers.
Technical & fundamental data as of Aug 7, 2026.
Open?$1.36
High?$1.42
Low?$1.36
Prev. Close?$1.33
Volume?91.8K
Avg. Volume?166.8K
VWAP?$1.39
Rel. Volume?0.55x
Bid / Ask
Bid?$1.17 × 100
Ask?$1.61 × 100
Spread?$0.44
Midpoint?$1.39
Valuation & Ratios
Market Cap?21.0M
Shares Out?15.1M
Float?13.2M
Float %?88.2%
P/E Ratio?N/A
P/B Ratio?28.55
EPS?-$0.80
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
Employees
24
Market Cap
21.0M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2014-04-10
Address
3655 NOBEL DRIVE
SAN DIEGO, CA 92122
Phone: 858-926-7655
SAN DIEGO, CA 92122
Phone: 858-926-7655
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?40
Z-Score?0
Momentum?71
Short Sent.?54
Piotroski F-Score?4/9Mixed
Altman Z-Score?-10.53Distress
Confidence?50%Low
Short InterestHigh
Short % of Float?4.55%Low
Short Interest?601.3K
Days to Cover?6.0
Free Float13.2M
Avg Daily Volume100.9K
Settlement Date2026-07-15
Financial Health
Current Ratio?1.03Adequate
Quick Ratio?1.03Adequate
Cash Ratio?0.88Adequate
Debt/Equity?0.81Moderate
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?28.55HIGH▾
Peers100
S&P3
P/S?18.12HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-0.3CHEAP▾
S&P97
EV/Sales?2.63CHEAP▾
Peers100
S&P66
Returns & Efficiency
ROE?-1,636.7%WEAK▾
S&P3
ROA?-43.2%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-10163918
Enterprise Value?$3.0M
Fundamentals ratios updated end of day